Canadian patient experiences of lupus nephritis: a qualitative analysis

被引:1
|
作者
Cardwell, Francesca S. [1 ]
Elliott, Susan J. [1 ]
Barber, Megan R. W. [2 ]
Cheema, Kim [3 ]
George, Sydney [4 ]
Boucher, Adrian [4 ]
Clarke, Ann Elaine [2 ]
机构
[1] Univ Waterloo, Dept Geog & Environm Management, Waterloo, ON, Canada
[2] Univ Calgary, Cumming Sch Med, Div Rheumatol, Calgary, AB, Canada
[3] Univ Calgary, Cumming Sch Med, Div Nephrol, Calgary, AB, Canada
[4] GSK, Hlth Outcomes & Econ, Mississauga, ON, Canada
来源
LUPUS SCIENCE & MEDICINE | 2023年 / 10卷 / 02期
关键词
Lupus Nephritis; Qualitative research; Quality of Life; OF-LIFE; MYCOPHENOLATE-MOFETIL; ERYTHEMATOSUS; CYCLOPHOSPHAMIDE;
D O I
10.1136/lupus-2023-000982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveLupus nephritis (LN) is one of the most severe manifestations of SLE; however, we know little about the lived experience of LN. This research investigates patient experiences and perspectives of (1) LN diagnosis; (2) living with LN; and (3) LN healthcare and treatment.MethodsPatients aged >= 18 years with biopsy-proven pure or mixed International Society of Nephrology/Renal Pathology Society class III, IV or V LN were purposefully recruited from a Canadian lupus cohort to participate in semistructured in-depth interviews.ResultsThirty patients with LN completed the interviews. The mean (SD) age was 42.1 (16.4) years, and 86.7% were female. Participants described challenges seeking, receiving and adjusting to a LN diagnosis, and some reported that their diagnosis process took weeks to years. While 16 participants were provided resources by healthcare providers to help them through the process of diagnosis, the need for accessible LN-specific information at diagnosis was highlighted (n=18). Participants also described the unpredictability of living with LN, particularly related to impacts on physical and mental health, relationships, leisure activities, employment and education, and family planning. While most (n=26) participants reported a positive impression of their care, the side effects of LN medications and the need to increase patient and societal awareness/understanding of LN were highlighted in the context of healthcare and treatment.ConclusionsThe unpredictability of living with LN, the heavy treatment burden and a lack of patient/societal awareness substantially affect the lived experience of LN. These findings will inform the development of LN-specific patient resources to increase understanding of LN and improve well-being for patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Cryptococcal granulomatous interstitial nephritis and dissemination in a patient with untreated lupus nephritis
    David, Vinoi George
    Korula, Anila
    Choudhrie, Lisa
    Michael, Joy Sarojini
    Jacob, Shibu
    Jacob, Chakko Korula
    John, George T.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) : 3243 - 3245
  • [22] PATIENT WITH MYASTHENIA GRAVIS,THYMOMA AND LUPUS NEPHRITIS
    GOLDIN, H
    ROBBINS, WC
    [J]. ARTHRITIS AND RHEUMATISM, 1963, 6 (03): : 272 - &
  • [23] Lupus Nephritis in a Patient with Sickle Cell Disease
    Minocha, Vinay
    Rana, Fauzia
    [J]. CASE REPORTS IN HEMATOLOGY, 2013, 2013
  • [24] Cutaneous Absidia corymbifera in a Lupus Nephritis Patient
    Sebastian, Kuruvilla K.
    Alzayer, Husam
    Abraham, Elizabeth
    Roche, Darren
    Reddan, Donal
    Lappin, David
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [25] RENAL AND PATIENT OUTCOME IN LUPUS NEPHRITIS WITH AKI
    Sharif, S. A.
    Ng, T. Z.
    Ibrahim, F. H.
    Goh, B. L.
    [J]. NEPHROLOGY, 2019, 24 : 35 - 36
  • [26] CURE OF CRYPTOCOCCEMIA IN AN IMMUNOCOMPROMISED PATIENT WITH LUPUS NEPHRITIS
    EISER, AR
    NEFF, MS
    SLIFKIN, RF
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1982, 2 (02) : 95 - 97
  • [27] Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis
    Toru Watanabe
    Hiroo Onda
    [J]. Pediatric Nephrology, 2004, 19 : 451 - 453
  • [28] Hematuria in a patient with class IV lupus nephritis
    Mittal, B. V.
    Pendse, S.
    Rennke, H. G.
    Singh, A. K.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (06) : 1182 - 1186
  • [29] mTOR inhibitors in a patient with lupus nephritis; why not?
    Berzal, Raquel
    Agredano, Beatriz
    Gil, Marco
    Galindo, Maria
    Morales, Enrique
    [J]. NEFROLOGIA, 2023, 43 : 100 - 102
  • [30] Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis
    Watanabe, T
    Onda, H
    [J]. PEDIATRIC NEPHROLOGY, 2004, 19 (04) : 451 - 453